2Poulou A, Dimitroulia E, Markou F, et al. Escherichia hermannii as the sole isolate from a patient with purulent conjunctivitis[J]. J Clin Microbiol,2008,46(11):3848-3849.
3Dahl K M, Barry J, DeBiasi R L. Escherichia hermannii infection of a cephalohematoma: case report, review of the literature, and description of a novel invasive pathogen[J]. Clin Infect Dis,2002,35 (9):96-98.
4Pien F D, Shrum S, Swenson J M, et al. Colonization of humanwounds by Escherichia vulneris and Escherichia hermannit[J]. J Clin Microbiol,1985,22(2):283-285.
5Coleman J L, Rogers R C, Benach J L. Selection of an escape variant of Borrelia burgdorferi by use of bactericidal rnonoclonal antibodies to OspB[J]. Infect lmmun,1992,60(8):3098-3104.
6Ariadna S, Maria J, Sven B, et al. A bactericidal antibody to Borrelia burgdorferi is directed against a variable region of the OspB protein[J]. Infect Immun.,1994, 62(5):2037-2045.
7Connolly S E, Thanassi D G, Benach J L. Generation of a complement-independent bactericidal IgM against a relapsing fever Borrelia[J]. J Immunol,2004,172(2): 1191-1197.
8Dadachova E, Nakouzi A, Bryan R A, et al. Ionizing radiation delivered by specific antibody is therapeutic against a fungal infection[J]. Proc Natl Acad Sci U S A,2003,100(19): 10942-10947.
9Moragues M D, Omaetxebarria M J, Elguezabal N, et al. A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C, albicans activities[J]. Infect Immun,2003,71 (9):5273-5279.
10Polonelli L, Magliani W, Conti S, et al. Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis[J]. Infect Immun, 2003,71(11):6205-6212.
